CLINICAL_TRIALS ClinicalTrials.gov record update

Immunogenicity Study of the Antibody Persistence and Booster Effect of PENTAXIM™ at 18 Months of Age Following a Primary Series of DTaP-IPV-HB-PRP~T Combined Vaccine or of PENTAXIM™ and ENGERIX B® PEDIATRICO at 2, 4, and 6 Months of Age in Healthy Argentinean Infants

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00303316
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:22.044521+00:00
Published At: 2013-02-22T00:00:00+00:00
Record Updated At: 2013-02-22
Results Posted At: 2013-02-22
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Diphtheria", "Tetanus", "Pertussis", "Poliomyelitis", "Hepatitis B"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2013-02-22"
protocolSection.identificationModule.nctId: "NCT00303316"
protocolSection.identificationModule.officialTitle: "Immunogenicity Study of the Antibody Persistence and Booster Effect of PENTAXIM\u2122 at 18 Months of Age Following a Primary Series of DTaP-IPV-HB-PRP~T Combined Vaccine or of PENTAXIM\u2122 and ENGERIX B\u00ae PEDIATRICO at 2, 4, and 6 Months of Age in Healthy Argentinean Infants"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2013-02-22"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.